Abstract：In China, there are a huge number of patients with chronic diseases, however, the quantities of clinicians and hospitals are relatively small. Remote cardiac monitoring technology can be utilized in achieving the balance between clinical supply and demand. The technology can be applied in checking, monitoring, and managing patients with cardiovascular disease, evaluating health status, and making realtime rapid diagnosis and emergency alarms for patients with critical diseases. Besides the technology, other remote monitoring technologies are applied in patients with cardiovascular disease at present, including multiple physiological parameters remote monitoring technology and imaging technology. The former refers to remote blood pressure monitoring, remote blood sugar monitoring, remote degree of blood oxygen saturation monitoring, remote sleeprelated breathing disorder monitoring, remote electrocardial vector, and threedimensional ECG, etc. The latter includes cardiac vascular ultrasound, computed tomography(CT), and nuclear magnetic resonance(NMR), etc. Remote cardiac monitoring technology proves to be not only practical, but also high in price ratio. For patients with chronic diseases, the most important aspect of the technology is heart rate management, arrhythmia management and timely warning in crisis situation. By close observation and early diagnosis of the condition variety of disease, and remote consultation, the hospitalization days, the medical expense and the admission rate are reduced.
[1]卫生部心血管病防治研究中心. 中国心血管病报告2013[M]. 北京：中国大百科全书出版社, 2014：1-9. [2] 中华医学会心血管病学分会, 中华心血管病杂志编辑委员会. 慢性稳定性心绞痛诊断与治疗指南[J]. 中华心血管病杂志, 2007, 35(3)：195-206.[3] 中华医学会心血管病学分会, 中华心血管病杂志编辑委员会. 中国心力衰竭诊断和治疗指南2014[J]. 中华心血管病杂志, 2014, 42(2)：98-122. [4] January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society[J]. J Am Coll Cardiol, 2014, 64(21)：e1-76.[5] Crossley GH, Boyle A, Vitense H, et al. The CONNECT (Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision) trial: the value of wireless remote monitoring with automatic clinician alerts[J]. J Am Coll Cardiol, 2011, 57(10)：1181-1189.[6] Varma N, Epstein AE, Irimpen A, et al. Efficacy and safety of automatic remote monitoring for implantable cardioverterdefibrillator follow-up: the Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) trial[J]. Circulation, 2010, 122(4)：325-332.[7] Crossley GH, Chen J, Choucair W, et al. Clinical benefits of remote versus transtelephonic monitoring of implanted pacemakers[J]. J Am Coll Cardiol, 2009, 54(22)：2012-2019.
2015, Vol. 24 
